BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

7 articles for DR Cameron

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain.EBI
Boehringer Ingelheim (Canada)
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.EBI
Boehringer Ingelheim Pharmaceuticals
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.EBI
Boehringer Ingelheim Pharmaceuticals
NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent.EBI
Boehringer Ingelheim (Canada)
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.EBI
Boehringer Ingelheim Pharmaceuticals
beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.EBI
Boehringer Ingelheim (Canada)
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofBDB
Novartis